DRYTEC

This brand name is authorized in Estonia, Lithuania, Poland, Singapore.

Active ingredients

The drug DRYTEC contains one active pharmaceutical ingredient (API):

1	Technetium ⁹⁹ᵐTc pertechnetate UNII 7V4KUP966U - SODIUM MOLYBDATE MO-99
	The pertechnetate ion distributes in the body similarly to the iodide ion, but is not organified. In contrast to the iodide ion, the pertechnetate is released unchanged from the thyroid gland. Pertechnetate concentrates in the thyroid gland, salivary glands, gastric mucosa and choroid plexus. It is used in nuclear medicine in several nuclear scanning procedures.
	Read more about Technetium ⁹⁹ᵐTc pertechnetate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09FX01	Technetium (99mTc) pertechnetate	V Various → V09 Diagnostic radiopharmaceuticals → V09F Thyroid → V09FX Various thyroid diagnostic radiopharmaceuticals
Discover more medicines within V09FX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1150647
LT	Valstybinė vaistų kontrolės tarnyba	1015341
PL	Rejestru Produktów Leczniczych	100116780
SG	Health Sciences Authority	12480P